Giant Cell Arteritis (GCA)

DBCOND0115353Cardiovascular DiseasesEye Disease

Giant Cell Arteritis (GCA) is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Giant Cell Arteritis · Horton's Disease · Horton Disease · Arteritis, Giant Cell · Giant Cells Arteritis
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0021147SNOMED CT155442004MedDRA10018250UMLSC0039483

What you can answer from here — as of October 23, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
58Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Giant Cell Arteritis (GCA) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In